Sonia Simonetti (S Simonetti)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Michele Iuliani, Sonia Simonetti, Leonardo Cristofani, Silvia Cavaliere, Alessio Cortellini, Marco Russano, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini, Francesco Pantano
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC). Journal for immunotherapy of cancer 12 (6) (2024)
Michele Iuliani, Sonia Simonetti, Leonardo Cristofani, Silvia Cavaliere, Alessio Cortellini, Marco Russano, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini, Francesco Pantano
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC). Journal for immunotherapy of cancer 12 (6) (2024)
F Pantano, Sonia Simonetti, Michele Iuliani, M J Guillen, C Cuevas, P Aviles, S Cavaliere, A Napolitano, A Cortellini, A Mazzocca, Lorenzo Nibid, G Sabarese, Giuseppe Perrone, M Gambarotti, A Righi, E Palmerini, S Stacchiotti, M Barisella, A Gronchi, S Valeri, M Sbaraglia, A P Dei Tos, G Tonini, B Vincenzi
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models. Oncogene (2024)
Michele Iuliani, Sonia Simonetti, Leonardo Cristofani, Silvia Cavaliere, Alessio Cortellini, Marco Russano, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini, Francesco Pantano
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC). Journal for immunotherapy of cancer 12 (6) (2024)
Michele Iuliani, Sonia Simonetti, Leonardo Cristofani, Silvia Cavaliere, Alessio Cortellini, Marco Russano, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini, Francesco Pantano
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC). Journal for immunotherapy of cancer 12 (6) (2024)
Francesco Pantano, Martine Croset, Keltouma Driouch, Natalia Bednarz-Knoll, Michele Iuliani, Giulia Ribelli, Edith Bonnelye, Harriett Wikman, Sandra Geraci, Florian Bonin, Sonia Simonetti, Bruno Vincenzi, Saw See Hong, Sofia Sousa, Klaus Pantel, Giuseppe Tonini, Daniele Santini, Philippe Clézardin
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions. Oncogene 40 (7) (2021)